The MicroStent HEAL Registry: Interim 6-Month Outcomes

One third of peripheral arterial disease (PAD) patients will advance to critical limb ischemia (CLI)/ chronic limb-threatening ischemia (CLTI), and end-stage disease progression, characterized by rest pain, tissue loss, gangrene, and amputation. Despite ameliorative progress, percutaneous transluminal angioplasty clinical outcomes remain suboptimal. There is still a lack of solutions to improve patency. The HEAL registry collects outcomes data for the treatment of predominantly CLI/CLTI patients implanted with the MicroStent, designed specifically for below-the-knee (BTK) intervention.

Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Marco Manzi, Koen R. Deloose, Andrej Schmidt, Dierk Scheinert, Thomas Zeller, Lieven Maene, Daniel van den Heuvel, Wouter Lansink, Luis Mariano Palena, Paolo Sbarzaglia, Marianne Brodmann, Michael Lichtenberg Source Type: research